41CG – Scaling – Pink
Plaque psoriasis
35CG – Scaling – Pink
Plaque psoriasis
17MA – More Purple
50-year-old male patient. Gradual onset, progressive course. 10 years duration.
16MM – More Purple
A male patient with pustular psoriasis presented with large purplish erythematous plaque with pustules and lakes of pus on the
15MM – More Purple
A male patient with pustular psoriasis presented with large purplish erythematous plaque with pustules and lakes of pus on the
14MM – More Purple
45-year-old male patient with pustular psoriasis presented with large erythematous to purple plaques with pustules and lakes of pus on
18AE – More Gray
45-year-old patient with a history of untreated or inadequately managed psoriasis, with no significant improvement from topical treatments (e.g., corticosteroids
14. CG – Pink
Plaque Color: Pink on Dark Skin
13. MM – Pink
26-year-old male patient with psoriasis vulgaris presented with multiple pink plaques with scaling on the extensor surface of the arms.
12. MM – Pink
30-year-old female patient with psoriasis vulgaris presented with multiple pink plaques with scaling on the forearms and hands.
<div class="addtoany_share_save_container
PC62
An 18-year-old male with guttate psoriasis presented with small purple and less pink plaques with some scaling over the extensor
PC60
A 52-year-old male patient with psoriasis vulgaris presented with purple plaques on the chest and abdomen with slight scaling.
<div
PC59
A 38-year-old male patient with plaque psoriasis presented with hyperpigmented plaques on both legs.
PC58
A 29-year old male patient presented with multiple erythematous plaques with silvery scale on the back.
PC57
47-year-old male patient with guttate psoriasis. Presented with small purple plaques with slight scaling on the trunk.
<div class="addtoany_share_save_container addtoany_content
PC56
26 -year-old male patient with psoriasis vulgaris. Presented with small purple plaques with slight scaling present on the flexor aspect
PC55
A 31-year-old male patient with plaque psoriasis. Patient presented with a prolonged history of topical steroid use, showing drug induced
PC54
26 -year-old male patient with plaque psoriasis presented with purple, indurated plaques. Plaques have slight scaling over the extensor extremities,
PC53
A 34-year-old male patient with plaque psoriasis presented with deep purple plaques with slight scaling on the front of the
PC52
A 34-year-old male patient with plaque psoriasis presented with deep purple plaques with slight scaling on the back of the
PC51
Patient presented with numerous scaly plaques on almost all of her body including her scalp. There was hyperkeratosis of the
PC49
A 60-year-old male with psoriasis presented with less pink and mild gray plaque in the nape of the neck.
<div
PC48
32-year-old male patient with psoriasis vulgaris. Presented with large plaques with scaling and erythematous/ pinkish base on the extremities and
PC47
A 38 -year-old male patient presented with erythematous, scaly lesions and desquamation associated with onycholysis and sub-ungual hyperkeratosis.
<div class="addtoany_share_save_container
PC46
Patient presented with numerous scaly plaques on almost all of her body including her scalp. There was hyperkeratosis of the
PC45
A middle aged male patient presented with purplish plaques. They have been present on his back for several months, but
PC41
62 year old patient with plaque type psoriasis mainly on the legs. Previously worked in the mines of an island
PC39
A 39 -year-old male patient with psoriasis vulgaris presented with less pink plaques with slight scaling on the extensor surface
PC38
A patient with pustular psoriasis presented with purple plaque on the abdomen with pustules and crust.
PC37
56-year-old male patient with psoriasis vulgaris. Presented with multiple purple plaques with thick scales on the front of his chest
PC36
60-year-old male patient with psoriasis vulgaris. Presented with thick scaled gray plaques on both arms and trunk.
<div class="addtoany_share_save_container addtoany_content
PC30
A young patient presents with hypopigmented plaque psoriasis.
PC19
44 -year-old patient with plaque type psoriasis. Tested positive for HIV in 2017and has CMV Retinitis. However, viral load is
PC18
37-year-old male Libyan patient with a known case of psoriasis vulgaris. Presented with generalized scaly purple plaques on face, trunk
PC14
A middle aged male presented with plaques over both feet and hands. He was treated with tapinarof 1% cream for
PC13
An elderly man presented with purplish plaques with scales that have been present on his legs for 5 years. Upon
PC11
A 27-year-old female presented with skin lesions that have been present for 3 years. Traditional medicine was tried with no
PC10
Patient with psoriasis presented with lichenoid or purple hue.
What's New
First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
Highlights from the 2026 American Academy of Dermatology (AAD) Annual Meeting: Diagnostic Complexity, Therapeutic Advances, and Emerging Research
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
International Collaboration Announced to Improve Care for Psoriasis and Psoriatic Arthritis in Latin America
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
Next Generation of Leaders: 2025 IPC Fellows Transition to Jr. Councilors
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
IPC Welcomes New Councilors Dr. Mari Løset and Dr. Maxwell Sauder
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
Recent Advances in Psoriasis: A Year in Review
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.